Funds holding BEONE MEDICINES LTD
ISIN US07725L1026 · United States · LEI 549300JFUK6FRD5MH739
- Fund holders
- 119
- Of which ETFs
- 19 100 other funds
- Value held
- 4.2B $ 280.5M SEK
- Share of capital
- 1.0 % of 1.5B shares on Jul 31, 2026
Other securities from the same issuer : BeOne Medicines Ltd (CH1391448177), BeOne Medicines Ltd (CNE100005XT6)
119 funds hold this company: 116 declare it in a regulatory filing, and this table serves those page by page; 3 more are read from the reports their funds publish, and are not in it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| New Perspective Fund New Perspective Fund | 2,663,960 | 791.1M $ | 0.52 % | 0.18 % | as of Mar 31, 2026 ↗ |
| VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS | 2,319,622 | 688.9M $ | 0.95 % | 0.16 % | as of Mar 31, 2026 ↗ |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 1,169,571 | 347.3M $ | 1.41 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 735,295 | 218.4M $ | 0.14 % | 0.05 % | as of Mar 31, 2026 ↗ |
| EUPAC Fund EUPAC Fund | 730,386 | 216.9M $ | 0.17 % | 0.05 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 660,957 | 195.2M $ | 2.88 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 624,896 | 198.1M $ | 0.24 % | 0.04 % | as of Feb 28, 2026 ↗ |
| PRIMECAP Odyssey Growth Fund PRIMECAP Odyssey Funds | 587,747 | 173.5M $ | 3.20 % | 0.04 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 529,143 | 157.1M $ | 1.93 % | 0.04 % | as of Mar 31, 2026 ↗ |
| New World Fund Inc New World Fund Inc | 523,290 | 154.5M $ | 0.18 % | 0.04 % | as of Apr 30, 2026 ↗ |
| American Funds Global Insight Fund American Funds Global Insight Fund | 374,007 | 110.4M $ | 0.54 % | 0.03 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price International Stock Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 239,789 | 70.8M $ | 0.51 % | 0.02 % | as of Apr 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 238,672 | 70.9M $ | 3.12 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Baird Chautauqua International Growth Fund Baird Funds Inc | 207,340 | 61.6M $ | 4.29 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 177,140 | 56.2M $ | 0.24 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 158,895 | 47.2M $ | 0.14 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 155,339 | 49.2M $ | 0.23 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Franklin Dynatech Fund Franklin Custodian Funds | 150,000 | 44.5M $ | 0.18 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Emerging Markets Opportunities Fund Fidelity Investment Trust | 135,238 | 39.9M $ | 0.13 % | 0.01 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Global Equities Account College Retirement Equities Fund | 117,620 | 34.9M $ | 0.10 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 90,000 | 28.5M $ | 0.46 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 88,740 | 26.4M $ | 0.11 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 87,672 | 27.8M $ | 1.90 % | 0.01 % | as of Feb 27, 2026 ↗ |
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 84,602 | 25.1M $ | 0.94 % | 0.01 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 78,700 | 23.4M $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 76,653 | 22.8M $ | 0.09 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Driehaus Emerging Markets Growth Fund Driehaus Mutual Funds | 62,158 | 18.5M $ | 0.44 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 56,078 | 158.6M SEK | 0.98 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Balanced Fund Fidelity Puritan Trust | 54,463 | 17.3M $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 49,225 | 14.6M $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 46,000 | 13.6M $ | 0.47 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 45,749 | 13.6M $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Capital Group Global Equity ETF Capital Group Global Equity ETF | 44,845 | 14.2M $ | 0.65 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Baird Chautauqua Global Growth Fund Baird Funds Inc | 43,979 | 13.1M $ | 3.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 41,698 | 13.2M $ | 0.25 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 40,622 | 12.1M $ | 3.25 % | 0.00 % | as of Mar 31, 2026 ↗ |
| American Funds International Vantage Fund American Funds International Vantage Fund | 37,728 | 11.1M $ | 0.43 % | 0.00 % | as of Apr 30, 2026 ↗ |
| New World Fund AMERICAN FUNDS INSURANCE SERIES | 35,234 | 10.5M $ | 0.27 % | 0.00 % | as of Mar 31, 2026 ↗ |
| CAPITAL GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 34,000 | 10.1M $ | 0.44 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 33,421 | 9.9M $ | 0.95 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Capital Group International Equity ETF Capital Group International Equity ETF | 29,958 | 9.5M $ | 0.48 % | 0.00 % | as of Feb 28, 2026 ↗ |
| American Funds Developing World Growth & Income Fund American Funds Developing World Growth & Income Fund | 29,686 | 9.4M $ | 0.37 % | 0.00 % | as of Feb 28, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 23,847 | 67.1M SEK | 2.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 20,150 | 6M $ | 0.14 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Emerging Markets Equities Fund Inc Emerging Markets Equities Fund Inc | 18,624 | 5.5M $ | 1.23 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 18,530 | 5.9M $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 17,023 | 47.9M SEK | 4.81 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PACE International Equity Investments PACE SELECT ADVISORS TRUST | 16,888 | 5M $ | 0.68 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Emerging Markets Equity Central Fund Fidelity Central Investment Portfolios LLC | 15,969 | 4.7M $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 15,000 | 4.5M $ | 0.44 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Capital Group New Geography Equity ETF Capital Group New Geography Equity ETF | 14,726 | 4.7M $ | 0.26 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 12,955 | 3.8M $ | 0.34 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THE EMERGING MARKETS SERIES DFA INVESTMENT TRUST CO | 11,697 | 3.5M $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Empower Emerging Markets Equity Fund EMPOWER FUNDS, INC. | 11,487 | 3.4M $ | 0.20 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 11,267 | 3.6M $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Emerging Markets Fund VanEck Funds | 11,000 | 3.3M $ | 1.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 10,395 | 3.1M $ | 2.29 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 10,157 | 3M $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nomura Focused Emerging Markets Equity ETF Nomura ETF Trust | 9,295 | 2.8M $ | 0.90 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 8,960 | 2.8M $ | 1.78 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Lazard Emerging Markets Equity Advantage Portfolio LAZARD FUNDS INC | 7,966 | 2.4M $ | 0.32 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 7,635 | 2.4M $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Global X Aging Population ETF GLOBAL X FUNDS | 5,772 | 1.8M $ | 2.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Franklin Alternative Strategies Fund Franklin Alternative Strategies Funds | 5,727 | 1.8M $ | 0.35 % | 0.00 % | as of Feb 27, 2026 ↗ |
| Emerging Markets Fund RUSSELL INVESTMENT CO | 5,706 | 1.7M $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 5,544 | 1.8M $ | 0.17 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP T. Rowe Price Structured Mid-Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 5,506 | 1.6M $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SLOW CAPITAL GROWTH FUND Valued Advisers Trust | 5,500 | 1.6M $ | 1.62 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 5,013 | 1.5M $ | 0.49 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Parametric Tax-Managed Emerging Markets Fund Eaton Vance Series Trust II | 4,425 | 1.3M $ | 0.23 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Global Growth Stock Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 3,990 | 1.2M $ | 0.12 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VY(R) T. ROWE PRICE DIVERSIFIED MID CAP GROWTH PORTFOLIO Voya Partners Inc | 3,591 | 1.1M $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Aquarius International Fund RBB Fund, Inc. | 3,359 | 1.1M $ | 0.13 % | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price International Stock Portfolio T. ROWE PRICE INTERNATIONAL SERIES, INC. | 3,019 | 896.6K $ | 0.38 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 2,980 | 885K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 2,965 | 875.5K $ | 1.48 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ULTRACHINA PROFUND ProFunds | 2,887 | 852.4K $ | 3.81 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VanEck VIP Emerging Markets Fund VanEck VIP Trust | 2,700 | 801.8K $ | 1.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dunham International Stock Fund Dunham Funds | 2,683 | 792.2K $ | 0.32 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Storebrand Emerging Markets Storebrand Asset Management AS | 2,449 | 6.9M SEK | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations International Equity Fund Brinker Capital Destinations Trust | 2,394 | 758.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PRAXIS INTERNATIONAL INDEX FUND Praxis Mutual Funds | 2,287 | 679.2K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Domini Impact Equity Fund Domini Investment Trust | 2,060 | 608.3K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Equity Fund MORGAN STANLEY PATHWAY FUNDS | 2,000 | 634K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 1,982 | 585.2K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Balanced K6 Fund Fidelity Puritan Trust | 1,950 | 618.1K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Parametric Emerging Markets Fund Eaton Vance Mutual Funds Trust | 1,900 | 561K $ | 0.26 % | 0.00 % | as of Apr 30, 2026 ↗ |
| National Security Emerging Markets Index ETF Northern Lights Fund Trust IV | 1,828 | 579.5K $ | 1.49 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 1,784 | 565.5K $ | 0.75 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Invesco V.I. Health Care Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 1,685 | 500.4K $ | 0.34 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 1,454 | 460.9K $ | 0.50 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SP Funds S&P World (ex-US) ETF SP Funds Trust | 1,284 | 379.1K $ | 0.24 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Voya VACS Series EME Fund Voya Mutual Funds | 1,233 | 364.1K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 1,214 | 360.5K $ | 0.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Blended Mid Cap Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,206 | 358.1K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP EMERGING MARKETS ProFunds | 1,155 | 343K $ | 1.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Franklin DynaTech VIP Fund Franklin Templeton Variable Insurance Products Trust | 1,014 | 301.1K $ | 0.19 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Emerging Markets Equity Fund American Century ETF Trust | 885 | 280.5K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VOYA MULTI-MANAGER EMERGING MARKETS EQUITY FUND Voya Mutual Funds | 880 | 259.8K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 839 | 249.2K $ | 0.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.81 % | as of Mar 31, 2026 ↗ |
| Baird Chautauqua International Growth Fund Baird Funds Inc | 4.29 % | as of Mar 31, 2026 ↗ |
| ULTRACHINA PROFUND ProFunds | 3.81 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 3.25 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Growth Fund PRIMECAP Odyssey Funds | 3.20 % | as of Apr 30, 2026 ↗ |
| Baird Chautauqua Global Growth Fund Baird Funds Inc | 3.16 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.12 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 2.88 % | as of Apr 30, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 2.31 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 2.29 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 112 | -13 | 13,974,493 | +2.7 % |
| 2026Q1 | 125 | +8 | 13,601,796 | -0.2 % |
| 2025Q4 | 117 | +10 | 13,626,585 | +4.4 % |
| 2025Q3 | 107 | -10 | 13,054,422 | -10.0 % |
| 2025Q2 | 117 | +12 | 14,505,259 | +3.8 % |
| 2025Q1 | 105 | +5 | 13,976,496 | -4.5 % |
| 2024Q4 | 100 | +14 | 14,642,327 | -1.9 % |
| 2024Q3 | 86 | -4 | 14,921,600 | -0.8 % |
| 2024Q2 | 90 | -2 | 15,046,434 | +6.2 % |
| 2024Q1 | 92 | -7 | 14,165,564 | -8.0 % |
| 2023Q4 | 99 | 15,389,277 |
Institutional managers
278 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 8,799,053 | 2.6B $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 4,975,181 | 1.5B $ | as of Mar 31, 2026 |
| Capital International Investors | 4,158,726 | 1.2B $ | as of Mar 31, 2026 |
| FMR LLC | 3,693,610 | 1.1B $ | as of Mar 31, 2026 |
| Capital World Investors | 1,622,687 | 481.9M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 1,034,306 | 307.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,032,298 | 306.6M $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 862,643 | 256.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 657,501 | 195.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 539,769 | 160.3K $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 465,000 | 138.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 464,472 | 137.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 415,330 | 123.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 405,273 | 120.4M $ | as of Mar 31, 2026 |
| Baird Financial Group, Inc. | 349,651 | 103.8M $ | as of Mar 31, 2026 |
| Capital International, Inc./CA/ | 302,243 | 89.8M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 259,731 | 77.1M $ | as of Mar 31, 2026 |
| Man Group plc | 241,922 | 71.8M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 241,426 | 71.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 204,846 | 60.8M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 201,641 | 59.9M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 196,429 | 58.3M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 184,356 | 54.7M $ | as of Mar 31, 2026 |
| CAPITAL INTERNATIONAL SARL | 173,879 | 51.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 172,643 | 51.3M $ | as of Mar 31, 2026 |
Declared shareholders of BEONE MEDICINES LTD
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Baker Bros. Advisors LP and 4 others | 8.00 % | 115,912,814 | as of Jun 11, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding BEONE MEDICINES LTD". https://titelia.com/en/stocks/beone-medicines-ltd-US07725L1026